Pharma

Strategic collaboration combines Innovent’s early-stage oncology innovation platform with Pfizer’s global development and commercial capabilities across 12 cancer programs.

As AI becomes more fluent in science writing, the line between sounding right and being right starts to blur.

NMPA approval of Enstilar® marks a key expansion for LEO Pharma in China, bringing a widely used topical psoriasis treatment to an estimated 6.5 million patients amid growing demand for innovative dermatology care.

The event brings together industry leaders in Munich to explore how quality functions are evolving into strategic, risk-based and digitally enabled systems in response to increasing regulatory complexity and innovation in pharmaceuticals and biotechnology.

Collaboration aims to develop species-specific binders to accelerate research and improve control of zoonotic diseases.

From AI-enabled GPCR discovery to partnership-driven growth, Nxera is redefining how medicines are built and commercialised.